| Non-DM pts (n = 1030) | DM pts treated with GLP-1 RA/SGLT-2i (n = 1030) | DM pts not treated with GLP-1 RA/SGLT-2i (n = 1030) | P value |
---|---|---|---|---|
In-hospital mortality | ||||
 n (%) | 27 (3%) | 35 (3%) | 40 (4%) | 0.10 (for trend) |
 OR (95% CI) | Reference | 1.31 (0.78–2.18) | 1.50 (0.91–2.46) | 0.11 (for trend) |
 OR (95% CI)* | – | Reference | 1.08 (0.67–1.76) | 0.24 |
Acute heart failure | ||||
 n (%) | 108 (10%) | 137 (13%) | 169 (16%) |  < .0001 (for trend) |
 OR (95% CI) | Reference | 1.31 (1.01–1.71) | 1.68 (1.29–2.17) |  < .0001 (for trend) |
 OR (95% CI)a | – | Reference | 1.31 (1.02–1.70) | 0.004 |
Severe AKI (RRT) | ||||
 n (%) | 13 (1%) | 3 (0.3%) | 17 (2%) | 0.39 (for trend) |
 OR (95% CI) | Reference | 0.23 (0.07–0.81) | 1.31 (0.63–2.72) | 0.039 (for trend) |
 OR (95% CI)a | – | Reference | 4.88 (1.36–17.6) | 0.02 |